{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:15:44Z","timestamp":1792278944623,"version":"4.4.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":48,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["823QN372"],"award-info":[{"award-number":["823QN372"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["821RC736"],"award-info":[{"award-number":["821RC736"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>High\u2010Dose Dual Therapy With Amoxicillin Has Shown Advantages to Eradicate <jats:styled-content style=\"fixed-case\"><jats:italic>Helicobacter pylori<\/jats:italic><\/jats:styled-content> (<jats:styled-content style=\"fixed-case\"><jats:italic>H. pylori<\/jats:italic><\/jats:styled-content>), but Not for Penicillin\u2010Allergic Patients. It Is Recommended That Cefuroxime Could Be an Alternative, but Whether Cefuroxime Could Be Used in Dual Therapy Has Not Been Reported. This Study Aimed to Compare the Efficacy, Safety, and Compliance of Cefuroxime\u2010Based Dual Therapy (<jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content>) With Cefuroxime\u2010Based Bismuth Quadruple Therapy (<jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content>) to Treat <jats:styled-content style=\"fixed-case\"><jats:italic>H. pylori<\/jats:italic><\/jats:styled-content> Infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>The Prospective, Multicenter, Open\u2010Label, Randomized Controlled Trial Was Conducted to Enroll Patients With Treatment\u2010Naive <jats:styled-content style=\"fixed-case\"><jats:italic>H. pylori<\/jats:italic><\/jats:styled-content> Infection From 9 Institutions. Patients Were Randomly Assigned to <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> Group (Cefuroxime 500\u2009Mg Three Times\/Day and Vonoprazan 20\u2009Mg Twice\/Day) or <jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content> Group (Cefuroxime 500\u2009Mg Twice\/Day, Levofloxacin 500\u2009Mg Once\/Day, Vonoprazan 20\u2009Mg Twice\/Day, and Bismuth 220\u2009Mg Twice\/Day), both for 14\u2009Days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>700 Patients (350 per Group) Were Enrolled. In the Intention\u2010To\u2010Treat Analysis, Eradication Rates Were 76.0% and 86.3% in <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> Group and <jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content> Group (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). In the Modified Intention\u2010To\u2010Treat Analysis, Eradication Rates Were 78.9% and 89.1% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the Per\u2010Protocol Analysis, Eradication Rates Were 80.2% and 91.2% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The Incidence of Adverse Events Was Significantly Lower in <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> Group Than <jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content> Group (14.4% vs. 29.8%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Non\u2010inferiority Was Confirmed Between <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content> Group (All <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.025). Compliance Was Good in Both Groups (96.0% vs. 92.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.073). Poor Adherence Was a Risk Factor for Reducing the Efficacy in Both Groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content> Was More Effective Than <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\"><jats:italic>H. pylori<\/jats:italic><\/jats:styled-content> Eradication, Which Might Be Recommended for Penicillin\u2010Allergic Patients. If There Were Contraindications or Intolerance of <jats:styled-content style=\"fixed-case\">CQT<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">CDT<\/jats:styled-content> Would Be an Alternative.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trail Registration<\/jats:title><jats:p>ChiCTR2300071210<\/jats:p><\/jats:sec>","DOI":"10.1111\/hel.70037","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:16:18Z","timestamp":1745817378000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Cefuroxime\u2010Based Dual Therapy With Quadruple Therapy in <i>Helicobacter pylori<\/i>\u2010Infected Treatment\u2010Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0057-6575","authenticated-orcid":false,"given":"Ji\u2010Yan","family":"Li","sequence":"first","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u2010Chun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Chibi General Hospital  Chibi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wuhan Third Hospital  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun\u2010Hua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology The First People's Hospital of Tianmen  Tianmen China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang\u2010Wu","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wuhan Fourth Hospital  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Wenchang People's Hospital  Wenchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-0672","authenticated-orcid":false,"given":"Zhen\u2010Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Nanjing First Hospital  Nanjing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Huangshi Central Hospital  Huangshi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De\u2010Min","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun\u2010Lian","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology The First People's Hospital of Tianmen  Tianmen China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong\u2010Tian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Chibi General Hospital  Chibi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao\u2010Qun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology Hubei Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Hubei University of Chinese Medicine  Wuhan China"},{"name":"Hubei Shizhen Laboratory  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6300-1460","authenticated-orcid":false,"given":"Pei\u2010Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology  Wuhan China"},{"name":"Department of Gastroenterology Wenchang People's Hospital  Wenchang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00070-5"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102022\u2010327745"},{"issue":"5","key":"e_1_2_10_4_1","first-page":"289","article-title":"Sixth Chinese National consensus Report on the Management of Helicobacter Pylori Infection (Treatment Excluded)","volume":"42","author":"Helicobacter pylori Study Group","year":"2022","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12597"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(17)30219-4"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070786"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4536-8"},{"issue":"2","key":"e_1_2_10_9_1","first-page":"137","article-title":"Research Progress of Amoxicillin and Proton Pump Inhibitor Dual Therapy for Helicobacter pylori Infection","volume":"42","author":"Han Y.\u2010Y.","year":"2022","journal-title":"Chinese Journal of Digestive Surgery"},{"issue":"11","key":"e_1_2_10_10_1","first-page":"745","article-title":"2022 Chinese National Clinical Practice Guideline on Helicobacter Pylori Eradication Treatment","volume":"42","author":"Helicobacter pylori Study Group CSoG","year":"2022","journal-title":"Chinese Journal of Digestive Surgery"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2662"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15917"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-023-02042-2"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.01.022"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002592"},{"issue":"6","key":"e_1_2_10_16_1","first-page":"426","article-title":"The Role and Research Progress of Acid Suppressants in Helicobacter pylori Infection Eradication","volume":"42","author":"Han Y.\u2010Y.","year":"2022","journal-title":"Chinese Journal of Digestive Surgery"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19283"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.02.005"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.05.035"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70101-X"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112829"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13073"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-017-4564-4"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1056-3"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.6.603"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(96)00162-9"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2020.03.006"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.3.344"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12271"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12714"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311019"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091311"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523\u20105378.1996.tb00003.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.10.036"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12596"},{"key":"e_1_2_10_36_1","volume-title":"The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book","author":"Infographics WA","year":"2022"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hel.70037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:43:48Z","timestamp":1748353428000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hel.70037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1111\/hel.70037"],"URL":"https:\/\/doi.org\/10.1111\/hel.70037","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2024-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70037"}}